TFS 2024 | Zheng Jun: Technical Improvements in Type I Arch Hybrid Procedures
时间: 2024-07-25
作者: 小编:
阅读量: 67
关键词:

Author: Zheng Jun

 

Affiliation: Peking Union Medical College Hospital

 

图片36.png


Introduction to Type I Arch Hybrid Procedures

 

Type I arch hybrid procedures address complex challenges associated with the aortic arch’s hemodynamics and anatomy, particularly the high amplitude pulsation in Zone 0, which increases the complexity and risk of these surgeries. The document emphasizes the evolution of techniques to improve perioperative outcomes and surgical success rates.

 图片37.png


Inherent Challenges and Technical Difficulties

 

Dynamic Blood Flow Impact: The main difficulty lies in managing the intense blood flow impact in Zone 0, increasing surgical complexity and risk.

Y-Graft Application: Although effective in providing support for branch vessels, creating a sufficient length for stable anchoring and controlling bleeding remains a challenge.

 

Perioperative Mortality and Endoleak Issues

 

Statistical Overview: A meta-analysis covering studies from 2000 to 2016 with 1021 patients shows a short-term mortality rate as high as 14% and an endoleak rate of 7.1% when dealing with Zone 0, highlighting the need for technical improvements.

 图片38.png

Technical Improvement Strategies

 

Optimized Graft Design: Introduction of dual “Y” shaped grafts to enhance branch vessel anastomosis and extend the anchoring zone to reduce risks of endoleaks and graft migration.

Stabilization Techniques: Methods such as wrapping the ascending aorta and part of the aortic arch are discussed to provide a stable anchoring area.

 图片39.png


Long-term Follow-up and Effects

 

Clinical Outcomes: A study from 2019 to 2022 involving 44 cases showed promising early and mid-term results. The procedures had a high success rate with a perioperative mortality rate of only 2.3%, without serious complications like transient paralysis, retro-tearing, endoleak, or migration.

 图片40.png


Conclusion and Future Outlook

 

Zheng Jun concludes by summarizing the current advancements in Type I arch hybrid technology, envisioning future developments, and emphasizing the importance of continuous innovation to enhance surgical safety and effectiveness.

 

Contact Us

 

For further information or inquiries about the techniques discussed or the Tian Fu Symposium, please leave a comment below or email us at: endovascluar@simtomax.cn.

 

For more details, visit our official website: www.vascularknight.com.

 

Follow Us on Social Media:

 

Facebook: Vasco Knight

Instagram: @knight_vasco

 

Thank you for your attention. Let’s collaborate for better health!